Gonadorelin

Gonadorelin is a synthetic analog of gonadotropin-releasing hormone (GnRH), the body's own signal for initiating sex hormone production. Its most common use in clinical peptide protocols is to preserve testicular function and fertility in men who are on testosterone replacement therapy (TRT) - though it is also relevant to fertility protocols in women. How it works: Gonadorelin prompts the pituitary gland to release LH (luteinizing hormone) and FSH (follicle-stimulating hormone). These hormones travel to the gonads and maintain their function. In men on TRT, exogenous testosterone suppresses the body's own LH and FSH, which over time can cause testicular atrophy and impair sperm production. Gonadorelin bypasses this suppression by providing the upstream pituitary signal directly. Who tends to use it: Gonadorelin is most commonly used by men on TRT who want to preserve fertility and testicular size and function during treatment. It is described as a replacement for HCG in many TRT protocols. It also has applications in female fertility protocols. Its primary goal is hormone support, with libido listed as a secondary target. What to expect: Gonadorelin is used on an ongoing basis alongside TRT rather than as a standalone or short cycle. Its effect is maintenance - keeping the gonadal axis functional rather than producing new symptomatic gains. How it is taken: Gonadorelin is given by subcutaneous injection, 2-3 times per week. Dose and exact timing are set per protocol. It is used on an ongoing basis concurrent with TRT. Safety notes: Gonadorelin is a compounded preparation. It is excluded during pregnancy. It pairs with kisspeptin-10 in hormonal protocols. No other specific cautions are listed beyond the clinical context of use. The decision to use gonadorelin, its dose, and how it integrates with TRT or other hormone protocols are all determined at a PepDepo consultation.